Comparison of risk of hyperkalemia between SGLT2 inhibitors and DPP4-inhibitors in patients with type 2 diabetes
1 December 2022 (08:00 - 19:00)
Organised by:
About the speaker
University of Hong Kong-Shenzhen Hospital, Shenzhen (China)
31 More presentations in this session
Doctor K. Wibawa (Cirebon, ID)
Doctor A. Baimbetov (Almaty, KZ)
Doctor A. Baimbetov (Almaty, KZ)
Doctor K. Powpuree (Bangkok, TH)
Doctor P. Mendiola (Makati, PH)
Access the full session
The Event
ESC Asia 2022 with APSC & AFC
1 December - 3 December 2022
You may be interested in
Congress Presentation
